找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

SCIE期刊DIABETES RESEARCH AND CLINICAL PRACTICE 2024/2025影响因子:6.164 (DIABETES RES CLIN PR) (0168-8227). (ENDOCRINOLOGY &

[复制链接]
楼主: 无缘无故
发表于 2025-3-27 00:12:55 | 显示全部楼层
Submitted on: 13 September 2012. Revised on: 02 January 2013. Accepted on: 28 January 2013. ___________________DIABETES RESEARCH AND CLINICAL PRACTICE
发表于 2025-3-27 04:41:13 | 显示全部楼层
Submitted on: 06 February 1999. Revised on: 25 March 1999. Accepted on: 14 May 1999. ___________________DIABETES RESEARCH AND CLINICAL PRACTICE
发表于 2025-3-27 09:14:45 | 显示全部楼层
Submitted on: 22 September 2022. Revised on: 29 November 2022. Accepted on: 28 January 2023. ___________________DIABETES RESEARCH AND CLINICAL PRACTICE
发表于 2025-3-27 13:09:06 | 显示全部楼层
Submitted on: 24 August 2012. Revised on: 16 October 2012. Accepted on: 07 December 2012. ___________________DIABETES RESEARCH AND CLINICAL PRACTICE
发表于 2025-3-27 17:35:05 | 显示全部楼层
Submitted on: 12 July 2019. Revised on: 23 August 2019. Accepted on: 27 September 2019. ___________________DIABETES RESEARCH AND CLINICAL PRACTICE
发表于 2025-3-27 20:17:42 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-4-27 00:45
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表